The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. Radical transparency is when ...

Thanks to the San Mateo County Civil Grand Jury for its recent report referenced in the July 15 article titled, “Grand jury calls for internal control assessments.” As the new permanent chancellor of ...

Hi, I'm <insert name here> and I'm an <insert demeaning label society has thrust upon you>. Aside from the stories you decide to share in a particular meeting, everything else about your identity will ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Even before he took ...

When the FDA turns down a drug application, it has historically been up to the drug company to reveal it. These FDA complete response letters, or CRLs, have not been considered public documents.

As the global financing environment tightens, some governments in the developing world are turning to off-budget and increasingly complex debt instruments that risk new hidden debts. In this episode ...

WASHINGTON — Even before he took over the Food and Drug Administration, Marty Makary called for frequent, transparent meetings of the independent panels that advise the agency on controversial ...